Vitiligo-like syndrome following the use of fluphenazine enanthate.
D000328:Adult; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy; D014820:Vitiligo / Q000139:chemically induced*
C017610:fluphenazine enanthate; D005476:Fluphenazine